View in EDS HTML Full Text PDF Full Text

Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients.

Saved in:
Bibliographic Details
Title: Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients.
Authors: Framil M; Immunology Department, Centre Diagnòstic Biomèdic, Hospital Clínic de Barcelona, Barcelona, Spain.; Immunology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., García-Serrano L; Immunology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Morandeira F; Immunology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Luchoro JF; Immunology Department, Centre Diagnòstic Biomèdic, Hospital Clínic de Barcelona, Barcelona, Spain., Antolí A; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain., Gomez-Vazquez JL; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., Sierra-Fortuny À; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain., Solanich X; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.; Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.
Source: Frontiers in immunology [Front Immunol] 2025 Mar 17; Vol. 16, pp. 1556731. Date of Electronic Publication: 2025 Mar 17 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2025.1556731